AGF INVESTMENTS INC. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.

Quarter-by-quarter ownership
AGF INVESTMENTS INC. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2017$98,000
-23.4%
8,8420.0%0.00%0.0%
Q4 2016$128,000
-41.0%
8,8420.0%0.00%
-50.0%
Q3 2016$217,000
+21.9%
8,8420.0%0.00%0.0%
Q2 2016$178,000
+71.2%
8,842
+121.9%
0.00%
+100.0%
Q1 2016$104,000
-99.8%
3,985
-98.9%
0.00%
-99.9%
Q3 2015$63,273,000
+713.8%
353,632
+908.6%
0.80%
+846.4%
Q2 2015$7,775,000
+19.0%
35,060
+5.8%
0.08%
+18.3%
Q1 2015$6,536,000
+19.6%
33,138
-13.2%
0.07%
+22.4%
Q4 2014$5,467,000
-2.0%
38,188
-10.3%
0.06%0.0%
Q3 2014$5,581,000
-5.6%
42,588
-8.9%
0.06%0.0%
Q2 2014$5,912,000
-2.7%
46,753
+1.3%
0.06%
-6.5%
Q1 2014$6,075,000
-59.1%
46,153
-63.5%
0.06%
-59.2%
Q4 2013$14,846,000
+7.3%
126,553
-4.7%
0.15%
-2.6%
Q3 2013$13,836,000
+13.5%
132,803
-6.1%
0.16%
+10.6%
Q2 2013$12,189,000141,4030.14%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2015
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders